These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9473176)

  • 1. Peripheral blood progenitor cell transplantation: impact on the pharmacy workload and budget.
    Davis TL
    Pharmacotherapy; 1998; 18(1 Pt 2):24S-29S. PubMed ID: 9473176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood progenitor cells: enabling outpatient transplantation.
    McGuire TR; Tarantolo S; Reed E
    Pharmacotherapy; 1998; 18(1 Pt 2):17S-23S. PubMed ID: 9473175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations.
    Gilbert CJ
    Pharmacotherapy; 1996; 16(3 Pt 2):101S-108S. PubMed ID: 8726589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood progenitor cell transplantation: economic issues.
    Yee GC
    Pharmacotherapy; 1998; 18(1 Pt 2):9S-16S. PubMed ID: 9473174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced charges and costs associated with outpatient autologous stem cell transplantation.
    Meisenberg BR; Ferran K; Hollenbach K; Brehm T; Jollon J; Piro LD
    Bone Marrow Transplant; 1998 May; 21(9):927-32. PubMed ID: 9613786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program.
    Frey P; Stinson T; Siston A; Knight SJ; Ferdman E; Traynor A; O'Gara K; Rademaker A; Bennett C; Winter JN
    Bone Marrow Transplant; 2002 Dec; 30(11):741-8. PubMed ID: 12439696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
    Bennett C; Waters T; Stinson T; Almagor O; Pavletic Z; Tarantolo S; Bishop M
    Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
    Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
    Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic evaluation of blood stem-cells autologous transplantation].
    Corroller AG; Fortanier C; Faucher C; Blaise D; Moatti JP
    Bull Cancer; 2001 Sep; 88(9):893-9. PubMed ID: 11604363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy.
    Glaspy JA
    Bone Marrow Transplant; 1999 May; 23 Suppl 2():S21-7. PubMed ID: 10335873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital.
    Kline RM; Meiman S; Tarantino MD; Herzig RH; Bertolone SJ
    Bone Marrow Transplant; 1998 Jan; 21(2):195-203. PubMed ID: 9489638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical services and inpatient drug costs in bone marrow transplantation.
    King RS; Wordell CJ; Haupt BA
    Am J Hosp Pharm; 1994 May; 51(10):1339-42. PubMed ID: 8085573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
    Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cooperative Care model: an innovative approach to deliver blood and marrow stem cell transplant care.
    Schmit-Pokorny K; Franco T; Frappier B; Vyhlidal RC
    Clin J Oncol Nurs; 2003; 7(5):509-14, 556. PubMed ID: 14603547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with autologous stem cell rescue in the outpatient setting.
    Dix SP; Geller RB
    Oncology (Williston Park); 2000 Feb; 14(2):171-85; discussion 185-6, 191-2. PubMed ID: 10736807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.
    Chandrasekar PH; Abraham OC; Klein J; Alangaden G; Chalasani G; Cassells L; Dansey R; Abella S; Karanes C; Peters W; Baynes R
    Clin Infect Dis; 2001 Feb; 32(4):546-51. PubMed ID: 11181116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial.
    Bolwell BJ; Pohlman B; Andresen S; Kalaycio M; Goormastic M; Wise K; Wakeling A; Dannley R; Overmoyer B
    Bone Marrow Transplant; 1998 Feb; 21(4):369-73. PubMed ID: 9509971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
    Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
    Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of inpatient and outpatient ASCT.
    Summers N; Dawe U; Stewart DA
    Bone Marrow Transplant; 2000 Aug; 26(4):389-95. PubMed ID: 10982285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer.
    De Rosa L; Lalle M; Pandolfi A; Pescador L
    Bone Marrow Transplant; 2001 May; 27(10):1031-5. PubMed ID: 11438817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.